Orexigen Therapeutics Inc., Contrave | featured news

FDA declines to approve Orexigen diet drug

Orexigen Therapeutics Inc. said Tuesday that U.S. health officials rejected its experimental weight loss pill Contrave and requested a new study ...

 

Subscribe to this RSS topic: Syndicate content